About the Study

Chronic Kidney Disease (CKD): A study on ferric citrate to maintain or improve iron and phosphate levels

This study is being done for children: • Between the ages of 13-17 years • Diagnosed with Chronic Kidney Disease; CKD 3-4 The purpose of this study is to determine how well ferric citrate will lower the level of FGF23 (the hormone that regulates phosphate levels in the blood) , maintain or correct anemia and iron levels in the blood and maintain normal levels of serum phosphate in children with CKD stages 3 and 4 that is, between 15% and 60% of normal function.

Interested in learning more?

Full Study Name: FIT4KID - Ferric citrate drug study for children with CKD